ArticleMolecular and cellular biochemistry2026

USP52 impedes malignant progression and cell stemness in prostate cancer by deubiquitinating RBM5 to down-regulate NCAPG2.

Hongliang Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.